{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:47:25Z","timestamp":1790084845753,"version":"4.0.1"},"reference-count":80,"publisher":"Oxford University Press (OUP)","issue":"13","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Significant lipid metabolism changes during pregnancy are essential for fetal development. However, when complicated by pre-existing cardiometabolic risk factors like obesity, hypertension, and diabetes, there is an increased risk for adverse maternal and fetal outcomes and future cardiovascular events. Despite the rising prevalence of maternal obesity and other co-morbidities, there continues to be a lack of clear guidelines for screening and treating dyslipidaemia during pregnancy. This review aims to highlight the physiological changes in lipid metabolism during pregnancy, explore the association between dyslipidaemia and adverse outcomes, summarize current treatment options, and identify research gaps pertaining to management of perinatal dyslipidaemia. Enhancing our understanding of dyslipidaemia in pregnancy is crucial for improving maternal and fetal health outcomes, guiding future offspring risk assessment, and informing therapy guidelines.<\/jats:p>","DOI":"10.1093\/eurjpc\/zwaf383","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T11:37:11Z","timestamp":1753961831000},"page":"2345-2353","source":"Crossref","is-referenced-by-count":4,"title":["Hyperlipidaemia in the peripartum: epidemiology, physiology, and treatment options"],"prefix":"10.1093","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4446-0901","authenticated-orcid":false,"given":"Nidhi H","family":"Patel","sequence":"first","affiliation":[{"name":"Department of Medicine, Emory University School of Medicine , Atlanta, GA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veena","family":"Agusala","sequence":"additional","affiliation":[{"name":"Department of Medicine, Emory University School of Medicine , Atlanta, GA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishwar D","family":"Chuckaree","sequence":"additional","affiliation":[{"name":"Department of Medicine, Emory University School of Medicine , Atlanta, GA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie","family":"Wang","sequence":"additional","affiliation":[{"name":"Emory Women's Heart Center and Emory Clinical Cardiovascular Research Institute, Emory University School of Medicine, Atlanta, GA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apoorva","family":"Gangavelli","sequence":"additional","affiliation":[{"name":"Department of Medicine, Emory University School of Medicine , Atlanta, GA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Padove","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Cardiology, Northside Hospital , Atlanta, GA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence S","family":"Sperling","sequence":"additional","affiliation":[{"name":"Emory Women's Heart Center and Emory Clinical Cardiovascular Research Institute, Emory University School of Medicine, Atlanta, GA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puja K","family":"Mehta","sequence":"additional","affiliation":[{"name":"Emory Women's Heart Center and Emory Clinical Cardiovascular Research Institute, Emory University School of Medicine, Atlanta, GA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"key":"2026092119574960000_zwaf383-B1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.siny.2008.09.004","article-title":"Normal and abnormal maternal metabolism during pregnancy","volume":"14","author":"Hadden","year":"2009","journal-title":"Semin Fetal Neonatal Med"},{"key":"2026092119574960000_zwaf383-B2","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1210\/jc.2012-1295","article-title":"Maternal lipid profile during early pregnancy and pregnancy complications and outcomes: the ABCD study","volume":"97","author":"Vrijkotte","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2026092119574960000_zwaf383-B3"},{"key":"2026092119574960000_zwaf383-B4","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/jama.2023.9043","article-title":"Trends in state-level maternal mortality by racial and ethnic group in the United States","volume":"330","author":"Fleszar","year":"2023","journal-title":"JAMA"},{"key":"2026092119574960000_zwaf383-B5"},{"key":"2026092119574960000_zwaf383-B6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/eurjpc\/zwae240","article-title":"Early-onset atherosclerotic cardiovascular disease","volume":"32","author":"Mousavi","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"2026092119574960000_zwaf383-B7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0735-1097(19)33776-3","article-title":"Screening for hyperlipidemia in pregnant women: an underutilized opportunity for early risk assessment","volume":"73","author":"Gopal","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026092119574960000_zwaf383-B8","volume-title":"Effect of Pregnancy on Lipid Metabolism and Lipoprotein Levels","author":"Wild","year":"2000"},{"key":"2026092119574960000_zwaf383-B9","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/eurheartj\/ehab892","article-title":"European society of cardiology: cardiovascular disease statistics 2021","volume":"43","author":"Timmis","year":"2022","journal-title":"Eur Heart J"},{"key":"2026092119574960000_zwaf383-B10","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"key":"2026092119574960000_zwaf383-B11","first-page":"283","article-title":"Racial\/ethnic differences in pregnancy-related hypertensive disease in nulliparous women","volume":"24","author":"Ghosh","year":"2014","journal-title":"Ethn Dis"},{"key":"2026092119574960000_zwaf383-B12","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/CIRCULATIONAHA.113.005757","article-title":"Racial\/ethnic differences in dyslipidemia patterns","volume":"129","author":"Frank","year":"2014","journal-title":"Circulation"},{"key":"2026092119574960000_zwaf383-B13","doi-asserted-by":"crossref","first-page":"e664","DOI":"10.1016\/j.jacl.2024.05.005","article-title":"Dyslipidemia management in women of reproductive potential: an expert clinical consensus from the National Lipid Association","volume":"18","author":"Agarwala","year":"2024","journal-title":"J Clin Lipidol"},{"key":"2026092119574960000_zwaf383-B14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0028-2243(92)90190-A","article-title":"Reference ranges of lipids and apolipoproteins in pregnancy","volume":"45","author":"Piechota","year":"1992","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2026092119574960000_zwaf383-B15","first-page":"Qc12","article-title":"Evaluation of lipid profile in second and third trimester of pregnancy","volume":"10","author":"Pusukuru","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"2026092119574960000_zwaf383-B16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jjcc.2012.09.009","article-title":"The current status of lipoprotein (a) in pregnancy: a literature review","volume":"61","author":"Fanshawe","year":"2013","journal-title":"J Cardiol"},{"key":"2026092119574960000_zwaf383-B17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1203\/PDR.0b013e3182055ede","article-title":"Obesity in pregnancy: implications for the mother and lifelong health of the child. A consensus statement","volume":"69","author":"Poston","year":"2011","journal-title":"Pediatr Res"},{"key":"2026092119574960000_zwaf383-B18","doi-asserted-by":"publisher","first-page":"700","DOI":"10.3390\/ijms23020700","article-title":"Maternal and neonatal polyunsaturated fatty acid intake and risk of neurodevelopmental impairment in premature infants","volume":"23","author":"Heath","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026092119574960000_zwaf383-B19","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1016\/j.cgh.2021.11.007","article-title":"Metabolic dysfunction-associated fatty liver disease and subsequent development of adverse pregnancy outcomes","volume":"20","author":"Lee","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026092119574960000_zwaf383-B20","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2020.03.049","article-title":"Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes","volume":"73","author":"Sarkar","year":"2020","journal-title":"J Hepatol"},{"key":"2026092119574960000_zwaf383-B21","doi-asserted-by":"crossref","first-page":"e003497","DOI":"10.1161\/CIRCOUTCOMES.116.003497","article-title":"Preeclampsia and future cardiovascular health: a systematic review and meta-analysis","volume":"10","author":"Wu","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2026092119574960000_zwaf383-B22","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/bmj.39366.416817.BE","article-title":"Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study","volume":"335","author":"Magnussen","year":"2007","journal-title":"BMJ"},{"key":"2026092119574960000_zwaf383-B23","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/eurjpc\/zwae165","article-title":"Exercise effects on maternal vascular health and blood pressure during pregnancy and postpartum: a systematic review and meta-analysis","volume":"31","author":"Pongpanit","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"2026092119574960000_zwaf383-B24","doi-asserted-by":"crossref","first-page":"150.e1","DOI":"10.1016\/j.ajog.2019.03.025","article-title":"Is maternal lipid profile in early pregnancy associated with pregnancy complications and blood pressure in pregnancy and long term postpartum?","volume":"221","author":"Adank","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"2026092119574960000_zwaf383-B25","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/aje\/kwu145","article-title":"Maternal hyperlipidemia and the risk of preeclampsia: a meta-analysis","volume":"180","author":"Spracklen","year":"2014","journal-title":"Am J Epidemiol"},{"key":"2026092119574960000_zwaf383-B26","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.amjhyper.2004.03.666","article-title":"Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia","volume":"17","author":"Enquobahrie","year":"2004","journal-title":"Am J Hypertens"},{"key":"2026092119574960000_zwaf383-B27","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00125-019-4840-2","article-title":"Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis","volume":"62","author":"Kramer","year":"2019","journal-title":"Diabetologia"},{"key":"2026092119574960000_zwaf383-B28","doi-asserted-by":"crossref","first-page":"100830","DOI":"10.1016\/j.eclinm.2021.100830","article-title":"Association of maternal lipid profile and gestational diabetes mellitus: a systematic review and meta-analysis of 292 studies and 97,880 women","volume":"34","author":"Hu","year":"2021","journal-title":"eClinicalMedicine"},{"key":"2026092119574960000_zwaf383-B29","doi-asserted-by":"crossref","first-page":"e000870","DOI":"10.1136\/bmjdrc-2019-000870","article-title":"Gestational diabetes and long-term risk for dyslipidemia: a population-based historical cohort study","volume":"8","author":"Chodick","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2026092119574960000_zwaf383-B30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1053\/j.semperi.2017.07.009","article-title":"Epidemiology of preterm birth","volume":"41","author":"Purisch","year":"2017","journal-title":"Semin Perinatol"},{"key":"2026092119574960000_zwaf383-B31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.tjog.2016.07.012","article-title":"Maternal dyslipidemia during pregnancy may increase the risk of preterm birth: a meta-analysis","volume":"56","author":"Jiang","year":"2017","journal-title":"Taiwan J Obstet Gynecol"},{"key":"2026092119574960000_zwaf383-B32","doi-asserted-by":"crossref","first-page":"610.e1","DOI":"10.1016\/j.ajog.2007.04.024","article-title":"Early pregnancy lipid concentrations and spontaneous preterm birth","volume":"197","author":"Catov","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"2026092119574960000_zwaf383-B33","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/ajh\/hpx020","article-title":"Retinol-binding protein 4 and lipids prospectively measured during early to mid-pregnancy in relation to preeclampsia and preterm birth risk","volume":"30","author":"Mendola","year":"2017","journal-title":"Am J Hypertens"},{"key":"2026092119574960000_zwaf383-B34","doi-asserted-by":"crossref","first-page":"e1002947","DOI":"10.1371\/journal.pmed.1002947","article-title":"Association of preterm birth with lipid disorders in early adulthood: a Swedish cohort study","volume":"16","author":"Crump","year":"2019","journal-title":"PLoS Med"},{"key":"2026092119574960000_zwaf383-B35","doi-asserted-by":"crossref","first-page":"102966","DOI":"10.1016\/j.dsx.2024.102966","article-title":"Maintaining an active lifestyle from adolescence to adulthood might alleviate the adverse association of preterm birth with cardiometabolic health","volume":"18","author":"Ezzatvar","year":"2024","journal-title":"Diabetes Metab Syndr"},{"key":"2026092119574960000_zwaf383-B36","doi-asserted-by":"crossref","first-page":"109416","DOI":"10.1016\/j.abb.2022.109416","article-title":"Oxidative stress, lipid peroxidation and premature placental senescence in preeclampsia","volume":"730","author":"Negre-Salvayre","year":"2022","journal-title":"Arch Biochem Biophys"},{"key":"2026092119574960000_zwaf383-B37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.placenta.2014.01.003","article-title":"Maternal obesity is associated with a lipotoxic placental environment","volume":"35","author":"Saben","year":"2014","journal-title":"Placenta"},{"key":"2026092119574960000_zwaf383-B38","doi-asserted-by":"crossref","first-page":"7250287","DOI":"10.1155\/2020\/7250287","article-title":"The late-gestational triglyceride to high-density lipoprotein cholesterol ratio is associated with neonatal macrosomia in women without diabetes Mellitus","volume":"2020","author":"Yu","year":"2020","journal-title":"Int J Endocrinol"},{"key":"2026092119574960000_zwaf383-B39","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12944-018-0707-7","article-title":"Association of maternal serum lipids at late gestation with the risk of neonatal macrosomia in women without diabetes mellitus","volume":"17","author":"Wang","year":"2018","journal-title":"Lipids Health Dis"},{"key":"2026092119574960000_zwaf383-B40","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0140-6736(99)02131-5","article-title":"Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: fate of early lesions in children (FELIC) study","volume":"354","author":"Napoli","year":"1999","journal-title":"Lancet"},{"key":"2026092119574960000_zwaf383-B41","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.clnu.2016.10.010","article-title":"Maternal early pregnancy lipid profile and offspring\u2019s lipids and glycaemic control at age 5\u20136 years: the ABCD study","volume":"36","author":"van Lieshout","year":"2017","journal-title":"Clin Nutr"},{"key":"2026092119574960000_zwaf383-B42","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/jamacardio.2015.0304","article-title":"Association of maternal prepregnancy dyslipidemia with adult offspring dyslipidemia in excess of anthropometric, lifestyle, and genetic factors in the framingham heart study","volume":"1","author":"Mendelson","year":"2016","journal-title":"JAMA Cardiol"},{"key":"2026092119574960000_zwaf383-B43","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/eurjpc\/zwab152","article-title":"Maternal hypercholesterolaemia during pregnancy affects severity of myocardial infarction in young adults","volume":"29","author":"Cacciatore","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"2026092119574960000_zwaf383-B44","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.3390\/ijerph18073701","article-title":"Relationships between maternal dietary patterns and blood lipid levels during pregnancy: a prospective cohort study in Shanghai, China","volume":"18","author":"Wang","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2026092119574960000_zwaf383-B45","doi-asserted-by":"crossref","first-page":"112056","DOI":"10.1016\/j.nut.2023.112056","article-title":"Relationship between diet quality and biochemical profile in Brazilian overweight pregnant women","volume":"113","author":"Carreira","year":"2023","journal-title":"Nutrition"},{"key":"2026092119574960000_zwaf383-B46","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1007\/s00394-023-03244-3","article-title":"Maternal diet quality and associations with plasma lipid profiles and pregnancy-related cardiometabolic health","volume":"62","author":"van der Pligt","year":"2023","journal-title":"Eur J Nutr"},{"key":"2026092119574960000_zwaf383-B47","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.ajog.2005.05.016","article-title":"Effect of a cholesterol-lowering diet on maternal, cord, and neonatal lipids, and pregnancy outcome: a randomized clinical trial","volume":"193","author":"Khoury","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"2026092119574960000_zwaf383-B48","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/bjsm.37.1.6","article-title":"Guidelines of the American college of obstetricians and gynecologists for exercise during pregnancy and the postpartum period","volume":"37","author":"Artal","year":"2003","journal-title":"Br J Sports Med"},{"key":"2026092119574960000_zwaf383-B49","doi-asserted-by":"crossref","first-page":"e37699","DOI":"10.2196\/37699","article-title":"Effects of structured supervised exercise training or motivational counseling on pregnant women\u2019s physical activity level: fitMum\u2014randomized controlled trial","volume":"24","author":"Knudsen","year":"2022","journal-title":"J Med Internet Res"},{"key":"2026092119574960000_zwaf383-B50","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.3390\/ijerph19063550","article-title":"The influence of maternal aerobic exercise, blood DHA and EPA concentrations on maternal lipid profiles","volume":"19","author":"Strom","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"2026092119574960000_zwaf383-B51","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ajmg.a.30386","article-title":"Mechanistic and epidemiologic considerations in the evaluation of adverse birth outcomes following gestational exposure to statins","volume":"131","author":"Edison","year":"2004","journal-title":"Am J Med Genet A"},{"key":"2026092119574960000_zwaf383-B52","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/1471-0528.12066","article-title":"Pregnancy outcome following maternal exposure to statins: a multicentre prospective study","volume":"120","author":"Winterfeld","year":"2013","journal-title":"BJOG"},{"key":"2026092119574960000_zwaf383-B53","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/tera.1420500604","article-title":"Developmental toxicity of the HMG-CoA reductase inhibitor, atorvastatin, in rats and rabbits","volume":"50","author":"Dostal","year":"1994","journal-title":"Teratology"},{"key":"2026092119574960000_zwaf383-B54","doi-asserted-by":"crossref","first-page":"1003060","DOI":"10.3389\/fphar.2022.1003060","article-title":"The effect of statins exposure during pregnancy on congenital anomalies and spontaneous abortions: a systematic review and meta-analysis","volume":"13","author":"Hirsch","year":"2022","journal-title":"Front Pharmacol"},{"key":"2026092119574960000_zwaf383-B55","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jacl.2016.07.002","article-title":"The risks of statin use in pregnancy: a systematic review","volume":"10","author":"Karalis","year":"2016","journal-title":"J Clin Lipidol"},{"key":"2026092119574960000_zwaf383-B56","doi-asserted-by":"crossref","first-page":"666.e1","DOI":"10.1016\/j.ajog.2021.05.018","article-title":"A randomized pilot clinical trial of pravastatin versus placebo in pregnant patients at high risk of preeclampsia","volume":"225","author":"Costantine","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"2026092119574960000_zwaf383-B57","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/CIRCULATIONAHA.121.053963","article-title":"Pravastatin versus placebo in pregnancies at high risk of term preeclampsia","volume":"144","author":"D\u00f6bert","year":"2021","journal-title":"Circulation"},{"key":"2026092119574960000_zwaf383-B58","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/1471-0528.16013","article-title":"Pravastatin for early-onset pre-eclampsia: a randomised, blinded, placebo-controlled trial","volume":"127","author":"Ahmed","year":"2020","journal-title":"BJOG"},{"key":"2026092119574960000_zwaf383-B59","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1080\/14767058.2021.1879785","article-title":"Pravastatin suppresses inflammatory cytokines and endothelial activation in patients at risk of developing preeclampsia: INOVASIA study","volume":"35","author":"Akbar","year":"2022","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2026092119574960000_zwaf383-B60","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1055\/a-1673-5603","article-title":"INOVASIA study: a randomized open controlled trial to evaluate pravastatin to prevent preeclampsia and its effects on sFlt1\/PlGF levels","volume":"41","author":"Akbar","year":"2024","journal-title":"Am J Perinatol"},{"key":"2026092119574960000_zwaf383-B61","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/toxsci\/41.1.88","article-title":"Pre- and postnatal toxicity of the HMG-CoA reductase inhibitor atorvastatin in rats","volume":"41","author":"Henck","year":"1998","journal-title":"Toxicol Sci"},{"key":"2026092119574960000_zwaf383-B62","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/j.amjmed.2013.02.032","article-title":"Rosuvastatin is transferred into human breast milk: a case report","volume":"126","author":"Schutte","year":"2013","journal-title":"Am J Med"},{"key":"2026092119574960000_zwaf383-B63","doi-asserted-by":"publisher","first-page":"e2022057988","DOI":"10.1542\/peds.2022-057988","article-title":"Policy statement: breastfeeding and the use of human milk","volume":"150","author":"Meek","year":"2022","journal-title":"Pediatrics"},{"key":"2026092119574960000_zwaf383-B64","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1093\/eurjpc\/zwae144","article-title":"Current treatments for the management of homozygous familial hypercholesterolaemia: a systematic review and commentary","volume":"31","author":"Gu","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"2026092119574960000_zwaf383-B65","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/eurjpc\/zwae028","article-title":"Beyond early LDL cholesterol lowering to prevent coronary atherosclerosis in familial hypercholesterolaemia","volume":"31","author":"Ibrahim","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"2026092119574960000_zwaf383-B66","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.atherosclerosis.2006.01.002","article-title":"Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia","volume":"189","author":"Amundsen","year":"2006","journal-title":"Atherosclerosis"},{"key":"2026092119574960000_zwaf383-B67","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11883-020-00881-5","article-title":"Women living with familial hypercholesterolemia: challenges and considerations surrounding their care","volume":"22","author":"Balla","year":"2020","journal-title":"Curr Atheroscler Rep"},{"key":"2026092119574960000_zwaf383-B68","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.atherosclerosis.2021.09.003","article-title":"Loss of statin treatment years during pregnancy and breastfeeding periods in women with familial hypercholesterolemia","volume":"335","author":"Klevmoen","year":"2021","journal-title":"Atherosclerosis"},{"key":"2026092119574960000_zwaf383-B69","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.atherosclerosis.2018.05.038","article-title":"Statins and other lipid-lowering therapy and pregnancy outcomes in homozygous familial hypercholesterolaemia: a retrospective review of 39 pregnancies","volume":"277","author":"Botha","year":"2018","journal-title":"Atherosclerosis"},{"key":"2026092119574960000_zwaf383-B70","doi-asserted-by":"crossref","first-page":"h1035","DOI":"10.1136\/bmj.h1035","article-title":"Statins and congenital malformations: cohort study","volume":"350","author":"Bateman","year":"2015","journal-title":"BMJ"},{"key":"2026092119574960000_zwaf383-B71","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/MOL.0000000000000980","article-title":"Familial hypercholesterolemia in pregnancy","volume":"36","author":"Alnouri","year":"2025","journal-title":"Curr Opin Lipidol"},{"key":"2026092119574960000_zwaf383-B72","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.jacc.2022.07.006","article-title":"2022 ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of Cardiology solution set oversight committee","volume":"80","author":"Lloyd-Jones","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026092119574960000_zwaf383-B73","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"2026092119574960000_zwaf383-B74","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/1753495X15594082","article-title":"Severe gestational hypertriglyceridemia: a practical approach for clinicians","volume":"8","author":"Wong","year":"2015","journal-title":"Obstet Med"},{"key":"2026092119574960000_zwaf383-B75","doi-asserted-by":"crossref","first-page":"e884","DOI":"10.1161\/CIR.0000000000000772","article-title":"Cardiovascular considerations in caring for pregnant patients: a scientific statement from the American Heart Association","volume":"141","author":"Mehta","year":"2020","journal-title":"Circulation"},{"key":"2026092119574960000_zwaf383-B76","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/eurjpc\/zwad402","article-title":"Genetically proxied low-density lipoprotein cholesterol lowering via PCSK9-inhibitor drug targets and risk of congenital malformations","volume":"31","author":"Ardissino","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"2026092119574960000_zwaf383-B77","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.atherosclerosis.2016.10.018","article-title":"Lipoprotein apheresis is essential for managing pregnancies in patients with homozygous familial hypercholesterolemia: seven case series and discussion","volume":"254","author":"Ogura","year":"2016","journal-title":"Atherosclerosis"},{"key":"2026092119574960000_zwaf383-B78","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/jca.20192","article-title":"Management of familial hypertriglyceridemia during pregnancy with plasma exchange","volume":"24","author":"Sivakumaran","year":"2009","journal-title":"J Clin Apher"},{"key":"2026092119574960000_zwaf383-B79","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00404-013-2786-z","article-title":"Therapeutic apheresis for severe hypertriglyceridemia in pregnancy","volume":"287","author":"Basar","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"2026092119574960000_zwaf383-B80","doi-asserted-by":"crossref","first-page":"153.e1","DOI":"10.1016\/j.ajog.2023.02.016","article-title":"Long-term neurodevelopmental follow-up of children exposed to pravastatin in utero","volume":"229","author":"Costantine","year":"2023","journal-title":"Am J Obstet Gynecol"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwaf383\/63928598\/zwaf383.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/33\/13\/2345\/63928598\/zwaf383.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/33\/13\/2345\/63928598\/zwaf383.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:58:01Z","timestamp":1790035081000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/article\/33\/13\/2345\/8221833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":80,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2025,8,4]]},"published-print":{"date-parts":[[2026,9,22]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwaf383","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2025,8,4]]}}}